Recent Posts on This Topic | See All >
[Source: TGen] - Dr. Heather Cunliffe, a scientific Investigator at the Translational Genomic Research Institute (TGen), will join the board of directors of the Phoenix Affiliate of Susan G. Komen for the Cure.
Dr. Cunliffe, the Head of TGen’s Breast and Ovarian Cancer Research Unit, begins her initial one-year term today on the 15-member board of the local Komen for the Cure affiliate, one of 125 such affiliates worldwide.
For more information: TGen scientist named to Phoenix board of Komen for the Cure
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.